PL360675A1 - Bicykliczne związki heteroaromatyczne - Google Patents

Bicykliczne związki heteroaromatyczne

Info

Publication number
PL360675A1
PL360675A1 PL36067501A PL36067501A PL360675A1 PL 360675 A1 PL360675 A1 PL 360675A1 PL 36067501 A PL36067501 A PL 36067501A PL 36067501 A PL36067501 A PL 36067501A PL 360675 A1 PL360675 A1 PL 360675A1
Authority
PL
Poland
Prior art keywords
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
compounds
heteroaromatic
Prior art date
Application number
PL36067501A
Other languages
English (en)
Other versions
PL207755B1 (pl
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL360675A1 publication Critical patent/PL360675A1/pl
Publication of PL207755B1 publication Critical patent/PL207755B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL360675A 2000-09-22 2001-09-17 Bicykliczny związek heteroaromatyczny, zawierająca go kompozycja farmaceutyczna i jego zastosowania PL207755B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (2)

Publication Number Publication Date
PL360675A1 true PL360675A1 (pl) 2004-09-20
PL207755B1 PL207755B1 (pl) 2011-01-31

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360675A PL207755B1 (pl) 2000-09-22 2001-09-17 Bicykliczny związek heteroaromatyczny, zawierająca go kompozycja farmaceutyczna i jego zastosowania

Country Status (31)

Country Link
US (2) US7229990B2 (pl)
EP (2) EP1886999A3 (pl)
JP (1) JP4977940B2 (pl)
KR (1) KR100860040B1 (pl)
CN (1) CN1247594C (pl)
AR (1) AR030784A1 (pl)
AT (1) ATE384726T1 (pl)
AU (2) AU2002213929B2 (pl)
BR (1) BR0113987A (pl)
CA (1) CA2422054C (pl)
CY (1) CY1107308T1 (pl)
CZ (1) CZ297136B6 (pl)
DE (1) DE60132607T2 (pl)
DK (1) DK1322651T3 (pl)
EC (1) ECSP034523A (pl)
ES (1) ES2299524T3 (pl)
HR (1) HRP20030220B1 (pl)
HU (1) HU229422B1 (pl)
IL (2) IL154624A0 (pl)
IS (1) IS2531B (pl)
MX (1) MXPA03002478A (pl)
NO (1) NO328683B1 (pl)
NZ (1) NZ524444A (pl)
PE (1) PE20020537A1 (pl)
PL (1) PL207755B1 (pl)
PT (1) PT1322651E (pl)
RU (1) RU2271360C2 (pl)
SK (1) SK287554B6 (pl)
TW (1) TWI290143B (pl)
WO (1) WO2002024703A1 (pl)
ZA (1) ZA200301588B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US7723342B2 (en) * 2005-05-17 2010-05-25 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2007136776A2 (en) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
CA2719868A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag Pyrimidinyl pyridone inhibitors of jnk.
WO2010047674A1 (en) 2008-10-20 2010-04-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
JP5965387B2 (ja) 2010-04-08 2016-08-03 アメリカ合衆国 Tsh受容体用のインバースアゴニストおよびニュートラルアンタゴニスト
PL2748166T3 (pl) 2011-08-23 2019-05-31 Asana Biosciences Llc Związki pirimido-pirydazynonowe oraz ich zastosowanie
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2127736C1 (ru) * 1992-06-22 1999-03-20 Берингер Ингельгейм КГ Производные анеллированного дигидропиридина или их соли с физиологически переносимыми кислотами и средство, блокирующее неселективные катионные каналы
TW276256B (pl) * 1993-08-26 1996-05-21 Takeda Pharm Industry Co Ltd
DK0765327T3 (da) * 1994-06-16 1999-11-29 Pfizer Pyrazolo- og pyrrolopyridiner
WO1997044041A1 (en) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds

Also Published As

Publication number Publication date
PT1322651E (pt) 2008-02-28
HUP0302648A3 (en) 2004-11-29
IL154624A (en) 2009-09-01
CZ297136B6 (cs) 2006-09-13
IS2531B (is) 2009-07-15
ZA200301588B (en) 2004-06-22
HUP0302648A2 (hu) 2003-11-28
US20030225113A1 (en) 2003-12-04
AU2002213929B2 (en) 2006-04-13
CN1462273A (zh) 2003-12-17
HK1054942A1 (en) 2003-12-19
AR030784A1 (es) 2003-09-03
PL207755B1 (pl) 2011-01-31
CA2422054C (en) 2011-01-11
JP2004509896A (ja) 2004-04-02
SK3312003A3 (en) 2003-08-05
DE60132607T2 (de) 2009-01-29
TWI290143B (en) 2007-11-21
AU1392902A (en) 2002-04-02
NO20031314D0 (no) 2003-03-21
RU2271360C2 (ru) 2006-03-10
HU229422B1 (hu) 2013-12-30
JP4977940B2 (ja) 2012-07-18
KR20030040483A (ko) 2003-05-22
EP1886999A8 (en) 2010-08-04
EP1886999A2 (en) 2008-02-13
SK287554B6 (sk) 2011-01-04
US7229990B2 (en) 2007-06-12
US7618963B2 (en) 2009-11-17
ATE384726T1 (de) 2008-02-15
EP1322651A1 (en) 2003-07-02
PE20020537A1 (es) 2002-06-20
ECSP034523A (es) 2003-04-25
ES2299524T3 (es) 2008-06-01
HRP20030220B1 (en) 2011-10-31
CA2422054A1 (en) 2002-03-28
CY1107308T1 (el) 2012-11-21
KR100860040B1 (ko) 2008-09-25
US20070197527A1 (en) 2007-08-23
DK1322651T3 (da) 2008-06-02
EP1886999A3 (en) 2008-03-12
NZ524444A (en) 2004-03-26
NO20031314L (no) 2003-03-21
CN1247594C (zh) 2006-03-29
MXPA03002478A (es) 2004-05-05
NO328683B1 (no) 2010-04-26
CZ2003828A3 (cs) 2003-08-13
BR0113987A (pt) 2003-08-12
EP1322651B1 (en) 2008-01-23
HRP20030220A2 (en) 2003-06-30
IS6732A (is) 2003-02-28
WO2002024703A1 (en) 2002-03-28
DE60132607D1 (de) 2008-03-13
IL154624A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
EP1349851A4 (en) COMPOUNDS
IL154624A (en) Bicyclic heteroaromatic compounds
AU2405002A (en) Dehalogeno compounds
GB0019950D0 (en) Compounds
PL369829A1 (pl) Podstawione związki 1H-chinolin-2-onowe
GB0028105D0 (en) Compounds
GB0003637D0 (en) Compounds
GB0009457D0 (en) Compounds
GB0003600D0 (en) Compounds
GB0003609D0 (en) Compounds
GB0019578D0 (en) Polysulphamated compounds
GB0014641D0 (en) Compounds
GB0003631D0 (en) Compounds
GB0003633D0 (en) Compounds
GB0003140D0 (en) Compounds
GB0020503D0 (en) Compounds
GB0002969D0 (en) Compounds
GB0015863D0 (en) Compounds
GB0015853D0 (en) Compounds
GB0015852D0 (en) Compounds
GB0014823D0 (en) Compounds
GB0014652D0 (en) Compounds
GB0014642D0 (en) Compounds
GB0003598D0 (en) Compounds
GB0006797D0 (en) Compounds